表紙
市場調査レポート

先進創傷ケア製品の世界市場

The Global Market for Advanced Wound Care Products 2014

発行 Espicom Business Intelligence 商品コード 316056
出版日 ページ情報 英文 281 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
先進創傷ケア製品の世界市場 The Global Market for Advanced Wound Care Products 2014
出版日: 2014年04月01日 ページ情報: 英文 281 Pages
概要

当レポートでは、世界の先進創傷ケア製品市場について調査し、市場概要の分析、背景情報、先進創傷ケア製品・技術に関する情報、および主要メーカーのプロファイルなどを提供しています。

市場概要

  • エグゼクティブサマリー

背景

  • 創傷ケア製品
  • 先進創傷ケア
  • 複雑な創傷:先進創傷ケアの役割
  • 現在の市場力学
  • 地域別の展望
  • 競合環境
  • 将来の市場展望

先進創傷ケア製品&技術

  • デバイスベースの創傷ケア
    • 陰圧創傷治療
    • 電気刺激
    • 超音波
    • 体外衝撃波療法
    • その他の創傷ケアデバイス

湿潤創傷ケア製品

  • ヒドロゲル
    • 新しいヒドロゲル技術
    • ハイドロコロイド被覆材
    • アルギン酸塩
    • フォーム被覆材
    • 複合被覆材
    • ソフトシリコン被覆材
    • 活性炭被覆材
    • 透明膜被覆材
    • 抗菌被覆材
      • 銀被覆材
      • はちみつ被覆材
      • ヨウ素被覆材
      • PHMB抗菌被覆材
      • その他の抗菌被覆材
      • 開発中のその他の製品

生物製剤

  • 市場力学
  • 規制環境
  • コラーゲンベースの創傷ケア製品
  • 代用皮膚
  • 成長因子
  • 細胞ベース療法
  • その他の生物学的製品
  • 酵素デブリードメント

その他の製品

  • 酸素に基づいた創傷被覆材
  • キトサン被覆材

創傷ケアメーカー

市場リーダー

その他の企業

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Advanced wound care products are used to treat complex and hard to heal wounds, including certain trauma, surgical and infected wounds, burns, and chronic wounds such as diabetic, venous and pressure ulcers.

Table of Contents

MARKET OVERVIEW

  • EXECUTIVE SUMMARY

BACKGROUND

  • Wound Care Products
  • Advanced Wound Care
  • Complex Wounds: The Role of Advanced Wound Care
    • Diabetic Foot Ulcers
    • Pressure Ulcers
    • Venous Stasis Ulcers
  • CURRENT MARKET DYNAMICS
    • Establishing Safety and Effectiveness
    • Regulatory Environment
  • REGIONAL PERSPECTIVE
  • COMPETITIVE ENVIRONMENT
    • Changing Industry Landscape
  • FUTURE MARKET PROSPECTS

ADVANCED WOUND CARE PRODUCTS & TECHNOLOGIES

  • DEVICE-BASED WOUND CARE
    • Negative Pressure Wound Therapy
      • Competitive Environment
      • Market Dynamics
      • Safety and Effectiveness of NPWT
        • FDA Preliminary Public Health Notice
      • Kinetic Concepts' V.A.C. Therapy
        • Current Product Portfolio
          • V.A.C. Clinical Studies
      • Smith & Nephew's NPWT Systems
        • RENASYS Products
        • PICO
      • Boehringer Technologies' Engenex NPWT System
      • Devon Medical's extriCARE NPWT System
      • Hartmann's Vivano NPWT System
      • Genadyne Biotechnologies' A4 and XLR8 NPWT Systems
      • Innovative Therapeutics' NPWT Systems
        • Pre-Clinical Study Results
      • Lohmann & Rauscher's Suprasorb CNP
      • Medela's Invia Liberty NPWT System
      • Mölnlycke Health Care's Avance and Advance Solo
      • Prospera's PRO NPWT Systems
      • Spiracur's SNaP System
        • Clinical Study Results
      • Spiracur's ciSNaP System
      • Talley Group's Venturi Systems
      • The Medical & WoundCare Company's Exsudex
      • In Development - PolyNovo Biomaterials' NovoPore TNP Dressing
    • Electrical Stimulation
      • BioElectronics' RecoveryRx
      • Mölnlycke Health Care's woundEL System
      • Synapse Microcurrent's Accel-Heal
      • Vomaris Wound Care's Procellera
        • Clinical Studies
    • Ultrasound
      • Arobella Medical's Qoustic Wound Therapy System
      • Celleration's MIST Therapy System
      • Misonix' SonicOne Ultrasonic Wound Debridement System
      • NanoVibronix' PainShield and WoundShield
      • Söring's Sonoca Systems
    • Extracorporeal Shock Wave Therapy
      • SANUWAVE's dermaPACE
        • PMA Studies
        • Clinical Studies
      • Tissue Regeneration Technologies' DermaGold
    • Other Wound Care Devices
    • Cure Care's WTS-2000
    • Regenesis Biomedical's Provant Wound Therapy System
    • SanoMed's SanoSkin Photizo Light Therapy Device

MOIST WOUND CARE PRODUCTS

  • Hydrogels
    • New Hydrogel Technologies
      • BioCure's GelSpray
      • Crawford Healthcare's KerraLite Cool
      • Nanotherapeutics' NanoDOX 1% Doxycycline Monohydrate Hydrogel
      • ULURU's Nanoflex Technology
    • Hydrocolloid Dressings
    • Alginates
    • Foam Dressings
      • Key and New Foam Technologies
        • ConvaTec's AQUACEL foam and Versiva XC Dressings
        • Coloplast's Biatain
        • Hartmann's HydroTac Products
        • Milliken Chemical's AFM Dressings
        • Mölnlycke Health Care's Mepilex Border Dressings
        • Smith & Nephew's Allevyn Dressings
    • Composite Dressings
    • 3M Tegaderm Matrix Dressing with PHI technology
    • Crawford Healthcare's KerraFibre
    • ConvaTec's Hydrofiber Dressings - AQUACEL & Versiva
    • Medline's Opticell
    • Smith & Nephew's DURAFIBER
    • Urgo's Lipido-Colloid Technology Dressings
      • Super-Absorbent Dressings
    • Soft Silicone Dressings
    • Activated Charcoal Dressings
    • Transparent Film Dressings
      • Mölnlycke Health Care's Mepitel Film AM and Mepitel Film IV AM
    • Antimicrobial Dressings
      • Silver Dressings
        • Clinical Evidence
        • Argentum Medical's Silverlon
        • B. Braun's Askina Calgitrol Paste
        • ConvaTec's AQUACEL Ag Products
        • Derma Sciences' ALGICELL Ag
        • Medline's Opticell Ag+
        • Milliken Chemical's AFM Dressings
        • Mölnlycke Health Care's Mepitel Film AM and Mepitel Film IV AM
        • Noble Biomaterials' SilverSeal and X-STATIC Technology
        • Smith & Nephew's Acticoat Dressings
        • Smith & Nephew's Other Silver Dressings
        • Systagenix' Silvercel and Actisorb Silver 220
        • Urgo's Silver Lipido-Colloid Technology Products
        • Silver Technologies in Development
      • Honey Dressings
        • Advancis Medical's Activon
        • Derma Sciences/Comvita's Medihoney
        • Medline's TheraHoney
        • SanoMed's Melladerm Plus
        • Triticum's L-Mesitran Range
      • Iodine-based Dressings
        • Archimed's Iodozyme and Oxyzyme
      • PHMB Antimicrobial Dressings
      • Other Antimicrobial Dressings
        • 3M's Tegaderm CHG
        • Derma Sciences' Dermagran
        • Hydrofera's Hydrofera Blue
        • Oculus Innovative Sciences' Microcyn Technology
        • Phytoceuticals' 1 PRIMARY WOUND DRESSING
        • Treatment of Scalp Wounds with Exposed Bone
        • Quick-Med Technologies' NIMBUS Technology
      • Other Products In Development
        • Innocoll's Cogenzia

BIOLOGICS

  • Market Dynamics
  • Regulatory Environment
  • Collagen-Based Wound Care Products
    • Cardium Therapeutics' Excellagen
      • Clinical Studies
    • Human BioSciences' SkinTemp II and Medfill II
    • Collagen Matrix' Matrix Collagen Dressing
    • Covalon Technologies' Biostep and ColActive
    • Eucare Pharmaceuticals
    • Hartmann's CollaSorb
    • Innocoll's CollaRx and CollaPress Products
    • Lescarden's Catrix Wound Dressing
    • Olympus Terumo Biomaterials' Terudermis Artificial Dermis
    • MedSkin Solutions Dr Suwelack's ProHeal Bio-Active Wound Therpay and Puracol Plus
    • Systagenix Collagen-Based Dressings
    • Wound Management Technologies' CellerateRx
    • Products in Development
      • Advanced Medical Solutions' RESORBA
      • Cardium Therapeautics' Genedexa
      • FibroGen's Synthetic Collagen
      • Innocoll's Cogenzia
  • Skin Substitutes
    • Changes to CMS Reimbursement
    • ACell's MatriStem
      • Study Results
    • Anika Therapeutics' HYAFF
    • Smith & Nephew/Cook Biotech's Oasis Wound Matrix Products
    • Integra LifeSciences' Collagen-Glycosaminoglycan Matrix
    • Kinetic Concepts/LifeCell's Graftjacket
    • Medestea Internazionale's Veloderm
    • MedSkin Solutions Dr Suwelack's Matriderm
    • MiMedx' EpiFix
      • Clinical Trial Results
      • FDA Letter
    • Organogenesis' Apligraf
    • Organogenesis' Dermagraft
      • Diabetic Foot Ulcer Health Economics Model
    • Osiris Therapeutics' Grafix
      • Clinical Studies
    • Promethean LifeSciences' GammaGraft and Repriza
    • Sanofi's Epicel Cultured Epidermal Autografts
    • UDL Laboratories/S&N's Biobrane
    • Products in Development
      • Derma Sciences/BioD's AmnioMatrix
      • PolyNovo Biomaterials' NovoSorb
  • Growth Factors
    • Kaken Pharmaceutical's Fiblast Spray
    • Smith & Nephew's Regranex (becaplermin) Gel 0.01%
      • Products in Development
    • Autologous Growth Factor Products
      • Cytomedix' AutoloGel System
      • SafeBlood Technologies' SafeBlood PlasmaDerm WD Procedure website down - recheck
  • Cell-Based Therapies
    • Avita Medical's ReCell Spray-On Skin
      • Development, Sales and Marketing Efforts
    • Tissue Genesis' IcellatorCell Isolation System
    • Products in Development
      • Cardium Therapeutics' Gene Activated Matrix Technology
      • Derma Sciences' DSC127
      • Garnet BioTherapeutics' GBT009
      • RegeneRx' RGN-137
      • Smith & Nephew's Cell-Based Therapies
  • Other Biologic Products
    • Mölnlycke's Oat Beta-Glucan
    • Mölnlycke's Xelma
    • Polyheal's Microsphere-Based Technology
    • Products in Development
      • Biotec Pharmacon's Woulgan biogel
  • Enzymatic Debriding Agents
    • Smith & Nephew's Collagenase Santyl Ointment
    • Maggot Therapy
    • Lohmann & Rauscher's Debrisoft
    • MediWound's NexoBrid

OTHER PRODUCTS

  • Oxygen-Based Wound Dressings
    • AcryMed's OxygeneSys Dissolved Oxygen Dressing
    • Oxygen Biotherapeutics' Wundecyte
    • sastOmed's Granulox
  • Chitosan Dressings
    • HemCon Medical Technologies
    • Aspen Medical Europe's KytoCel
    • Marine Polymer Technologies' Talymed
    • Sangui BioTech's Chitoskin

WOUND CARE MANUFACTURERS

THE MARKET LEADERS

  • 3M
    • Current Alliances
      • Becton Dickinson
      • Kinetic Concepts
      • Greystone Pharmaceuticals
  • Centaur Guernsey (Kinetic Concepts, LifeCell and Systagenix)
    • V.A.C. Therapy
      • Current Product Portfolio
    • LifeCell Products
    • Systagenix Operations
      • Advanced Wound Care Products
      • Wound Care Diagnostics
    • Current Alliances and Contracts
      • Noble Biomaterials
      • Novation
      • Wright Medical Group
      • 3M
    • Litigation
      • Wake Forest University
      • Vital Needs International
      • LifeNet Health
    • Financial Performance
  • Coloplast
    • Current Alliances
      • Devon Medical
      • Johnson & Johnson
    • Financial Performance
      • Latest Results and Outlook
  • ConvaTec
    • Wound Care Product Portfolio
    • Current Alliances
      • Boehringer Technologies
    • Litigation
      • Smith & Nephew
      • Kinetic Concepts and Wake Forest University
    • Financial Performance
      • Latest Results
  • Covidien
    • Advanced Wound Care Products
    • Financial Performance
      • Latest Results
  • Hartmann Group
    • Advanced Wound Care Products
      • Vivano NPWT System
    • Financial Performance
      • Latest Results and Outlook
  • Medline Industries
    • Advanced Wound Care Products
    • Current Alliances
      • Derma Sciences
      • ACell
      • Avery Dennison Medical
      • AcryMed
      • Lohmann & Rauscher
      • Dr Suwelack Skin & Health Care
  • Mölnlycke Health Care
    • Wound Care Portfolio
    • Avance Solo NPWT System
    • Mepilex Border Dressings
    • Mergers & Acquisitions
      • Gerromed's woundEL Electrical Stimulation Technology
      • Brennen Medical's Burn and Wound Care Business
    • Current Alliances and Supply Contracts
      • Covalon Technologies
      • VA National Contracting Office
      • Medela
    • Financial Performance
  • Smith & Nephew
    • Advanced Wound Care Products
      • NPWT
      • Moist Wound Care
  • Advanced Wound Bioactives
    • Bioactives Research and Development
      • HP802-247
    • Current Alliances
      • Biotec Pharmacon
      • Covalon Technologies
      • UDL Laboratories
      • Lescarden/Valeant Pharmaceuticals
    • Litigation with Wake Forest University and Kinetic Concepts
    • Financial Performance

OTHER COMPANIES

  • Absorbest
  • ACell
  • AcryMed (Kimberly-Clark)
  • Adocia
  • Advanced Medical Solutions
    • Current Agreements
      • Sinclair IS Pharma
      • Systagenix Wound Management
      • B. Braun
    • Financial Performance
  • Advancis Medical
  • Anika Therapeutics
  • Argentum Medical
  • Arobella Medical
  • Aspen Medical Europe (Hill-Rom)
  • Avita Medical
    • ReCell Spray-On Skin
      • Chronic Ulcers
      • Burns
      • Dyspigmentation
    • Financial Performance
  • B. Braun
  • BioCure
  • BioElectronics
    • Product Applications and Approvals
  • BioMonde/ZooBiotic
  • Biotec Pharmacon
    • Woulgan biogel
  • Boehringer Laboratories
  • Cardium Therapeutics
    • Excellagen
    • Research & Development
      • Genedexa
    • Current Alliances and Contracts
      • Kasiak Holdings
      • Orbsen Therapeutics and the National University of Ireland, Galway
      • AvKARE
      • Advanced Biosciences Research
      • Angel Biomedical
      • Smith Medical Partners
      • BL&H Co Ltd
  • Celleration
  • Collagen Matrix
  • Comvita
    • Alliance with Derma Sciences
    • Manuka Research Partnership
    • Financial Performance
    • Latest Results
  • Covalon Technologies
    • Current Alliances
      • Mölnlycke Health Care
      • Distribution Agreements
      • Mitec Telecom
    • Financial Performance
  • Crawford Healthcare
    • Current Agreements
      • Sun Healthcare
      • Exciton Technologies
      • Darco GmbH & Co
      • Flen Pharma
  • Cure Care
  • Cytomedix
    • AutoloGel System
    • New-Generation System
    • Financial Performance
      • Latest Results
  • DermaRite Industries
  • Derma Sciences
    • Advanced Wound Care Products
    • Research & Development - DSC127
      • Phase II Clinical Study
      • Pharmacokinetic study
      • Phase III Studies
    • Current Alliances and Licensing Agreements
      • BioD
      • Quick-Med Technologies
      • Comvita
      • University of Southern California
    • Financial Performance
      • Fiscal 2013 and 2014
  • DeRoyal
  • Devon Medical
  • Eucare Pharmaceuticals
  • Ferris
  • FibroGen
  • First Water
  • Garnet BioTherapeutics
  • Genadyne Biotechnologies
  • Gentell
  • HemCon Medical Technologies
  • Hollister Wound Care
  • Human BioSciences
  • Hydrofera
  • Innocoll
    • In Development - Cogenzia
  • Innovative Therapies
    • Litigation with Kinetic Concepts and Wake Forest University
  • Integra LifeSciences Holdings
  • Kaken Pharmaceutical
  • Kikgel
  • Kuros Biosurgery
  • Laboratoires Brothier
  • Lescarden
    • Financial Performance
  • LM Farma
  • Lohmann & Rauscher
  • Marine Polymer Technologies
    • Litigation with HemCon Medical Technologies
  • Medela
    • Litigation with Wake Forest University
  • Medestea Internazionale
  • MediWound
    • Polyheal
  • MedSkin Solutions Dr. Suwelack
  • Milliken Chemical
  • MiMedx Group
    • FDA Letter
    • Financial Performance
  • Misonix
    • Current Alliances
      • Technical Communities
    • Financial Performance
      • Latest Results
  • Nanotherapeutics
  • NanoVibronix
  • Noble Biomaterials
  • Oculus Innovative Sciences
    • Financial Performance
      • Latest Results
  • Olympus Terumo Biomaterials
  • Organogenesis
  • Osiris Therapeutics
  • Oxygen Biotherapeutics
  • Phytoceuticals
  • PolyNovo Biomaterials
    • NovoSorb BTM
      • NovoPore NovoSorb TNP Dressing
      • NovoSorb BTM for Surgical Wounds
      • NovoSorb BTM for Burns
  • Promethean LifeSciences
  • Prospera
  • Quick-Med Technologies
    • Intellectual Property
    • Contracts, Licensing and Development Agreements
      • US Department of Defense Contract
      • Viridis BioPharma
      • Derma Sciences
      • University of Florida
    • Financial Performance
  • RegeneRx Biopharmaceuticals
    • RGN-137
    • Current Alliances
      • Lee's Pharmaceuticals
      • Sigma-Tau
      • US National Institutes of Health
  • Regenesis Biomedical
  • SafeBlood Technologies
  • Sangui BioTech International
  • Sanofi Biosurgery
  • SanoMed Manufacturing
  • SANUWAVE Health
    • dermaPACE
      • PMA Studies
    • Financial Performance
      • Latest Results
  • Sorbion
  • Söring
  • Southwest Technologies
  • Spiracur
  • Synapse Microcurrent
  • Talley Group
  • The Medical & WoundCare Company
  • Tissue Genesis
  • Tissue Regeneration Technologies
  • Triticum
  • UDL Laboratories
  • ULURU
    • Altrazeal
    • Nanoflex Powder
    • Financial Performance
      • Latest Results
  • Urgo
    • Financial Performance
  • Vibrant Medical
  • Vomaris Wound Care
  • Wound Management Technologies
    • Current Agreements
      • Academy Medical
      • WellDyne
      • Applied Nutritionals
    • Financial Performance
      • Latest Results

APPENDICES

  • APPENDIX 1 - LIST OF ABBREVIATIONS
  • APPENDIX 2 - REPORT METHODOLOGY
    • Secondary Sources
    • Market forecasts
Back to Top